Theranostics: An Iron Oxide Nanocarrier for dsRNA to Target Lymph Nodes and Strongly Activate Cells of the Immune System (Small 24/2014)-Reference-Cited by-同舟云学术

Theranostics: An Iron Oxide Nanocarrier for dsRNA to Target Lymph Nodes and Strongly Activate Cells of the Immune System (Small 24/2014)

Published:2014-12 Issue:24 Volume:10 Page:5053-5053
ISSN:1613-6810
Container-title:Small
language:en
Short-container-title:Small

Author:

Cobaleda-Siles Macarena¹,Henriksen-Lacey Malou¹,de Angulo Ane Ruiz¹,Bernecker Anja¹,Vallejo Vanessa Gómez¹,Szczupak Boguslaw¹,Llop Jordi¹,Pastor Géraldine¹,Plaza-Garcia Sandra¹,Jauregui-Osoro Maite²,Meszaros Levente K.²,Mareque-Rivas Juan C.¹³

Affiliation:

1. Theranostic Nanomedicine Laboratory; CIC biomaGUNE; Paseo Miramón 182 20009 San Sebastián Spain

2. Division of Imaging Sciences & Biomedical Engineering; King's College London; St. Thomas' Hospital; London UK

3. IKERBASQUE, Basque Foundation for Science; 48011 Bilbao Spain

Publisher

Wiley

Subject

Biomaterials,Biotechnology,General Materials Science,General Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/smll.201470156/fullpdf

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redox‐Triggered Nanomedicine via Lymphatic Delivery: Inhibition of Melanoma Growth by Ferroptosis Enhancement and a Pt(IV)‐Prodrug Chemoimmunotherapy Approach;Advanced Therapeutics;2022-11-14

2. The surface coating of iron oxide nanoparticles drives their intracellular trafficking and degradation in endolysosomes differently depending on the cell type;Biomaterials;2022-02

3. Inorganic nanoconjugates for cancer theragnosis;Nanotherapeutics in Cancer Vaccination and Challenges;2022

4. Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer;Materials Today;2021-11

5. Design of PD-1-decorated nanocages targeting tumor-draining lymph node for promoting T cell activation;Journal of Controlled Release;2021-05